Esperion Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 150,000 N/A N/A
Option
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 10,700 N/A N/A
Option
MAYLEBEN TIMOTHY M director, officer: President & ..
Stock Option (right to buy) 10,700 N/A N/A
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 200,000 $25.31 $5,062,200
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 2,500 $43 $107,500
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 N/A N/A
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 20,000 $52.12 $1,042,400
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 75,000 $37.3 $2,797,575
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 $36.98 $184,900
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 2,500 $35.25 $88,125
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 80,000 $33.78 $2,702,240
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 $33.82 $169,100
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 $33.82 $169,100
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 $39.56 $197,800
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 50,000 N/A N/A
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 $46 $230,000
Sale
BARTRAM RICHARD officer: Chief Financial Officer
Common Stock 8,000 $43.17 $345,320
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 $40 $200,000
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 $43.48 $217,400
Sale
VITULLO NICOLE director
Common Stock 15,329 $44.96 $689,115
Sale
VITULLO NICOLE director
Common Stock 15,329 $44.96 $689,115
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 50,000 N/A N/A
Purchase
MAYLEBEN TIMOTHY M director, officer: President & ..
Common Stock 5,000 $48.73 $243,650
Sale
NEWTON ROGER S director
Common Stock 25,000 N/A N/A
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 80,000 $41.29 $3,303,280
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 50,000 $39.92 $1,995,750
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 60,000 $47.74 $2,864,100
Sale
BOXER CAPITAL, LLC 10 percent owner
Common Stock 60,000 $57.89 $3,473,580
Sale
NEWTON ROGER S director
Common Stock 227 N/A N/A
Sale
BOXER CAPITAL, LLC 10 percent owner
Common Stock 40,000 $54.95 $2,198,000
Sale
NEWTON ROGER S director
Common Stock 2,600 N/A N/A
Sale
NEWTON ROGER S director
Common Stock 100 $50 $5,000
Sale
NEWTON ROGER S director
Common Stock 12,673 $50.02 $633,903
Sale
NEWTON ROGER S director
Common Stock 9,400 $50.01 $470,094
Sale
NEWTON ROGER S director
Common Stock 17,700 $51.98 $920,099
Sale
NEWTON ROGER S director
Common Stock 7,300 $50.06 $365,438
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 50,000 $46.14 $2,306,950
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 50,000 $41.77 $2,088,300
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 50,000 $39.48 $1,973,800
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 60,000 $38.57 $2,314,200
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 60,000 $37.79 $2,267,280
Option
GOLDSTEIN DOV A MD director
Common Stock 13,000 $7.21 $93,730
Option
GOLDSTEIN DOV A MD director
Stock Option (right to buy) 5,000 $14.42 $72,100
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 60,000 $38.47 $2,308,440
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 80,000 $38.77 $3,101,760
Purchase
BIOTECH TARGET N V 10 percent owner
Common Stock 50,000 $42.24 $2,112,000
Sale
NEWTON ROGER S director
Common Stock 25,000 $71.91 $1,797,750
Sale
NEWTON ROGER S director
Common Stock 15,956 $71.46 $1,140,216
Option
NEWTON ROGER S director
Common Stock 34,651 $6.99 $242,210
Option
NEWTON ROGER S director
Warrant to Purchase Common Stock 34,651 $6.99 $242,210

Showing 50 to 100 of 157 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.